Carmat
Since 1996, Marc Grimmé has been the technical lead on the programme to develop the Carmat bioprosthetic heart.
He began his career in 1991 at MBDA France, where he worked on a range of issues linked to the development of mission-critical electronics, from upstream studies and the design phase to production commissioning.
Marc Grimmé is a graduate of the Institute Supérieur d’Electronique et du Numérique (ISEN).
This person is not in any offices
Carmat
CARMAT is a medical device company developing the world’s most advanced total artificial heart. CARMAT aims to eventually provide a response to a major public health issue associated with heart disease, the world’s leading cause of death: chronic and acute heart failure.